The building blocks of Quality Family Planning and Reproductive Healthcare Equity

Relativity applies to physics, not ethics
— Albert Einstein.
Autonomy and respect for persons is based on the concept that “individuals have the right to their own beliefs and values and to the decisions and choices that further these beliefs and values” (Longest, 2016). Quality family planning can uphold this principle by following a person-centered approach that not only solicits the values of the person being served, but takes these preferences seriously and supports the individuals progress towards self-determination by providing accurate information and a full range of options for care to enable the person to obtain the care they desire.
In a vulnerable population, individuals may be a greater risk of the opposite force, paternalism, which is when someone else determines what is best for people (Longest, 2016). Clear efforts must be made to protect people from paternalism and promote autonomy and self-determination. “Person-centered” family planning is founded on this core ethical principles. Family planning programs tailored to women suffering from or in recovery from substance use disorders would do well to model their practices on this evidence-based framework that priorities ethics and the person’s experience of care over the relatively arbitrary outcome of contraception uptake or contraception type chosen.
Justice is another critical ethical principle germane to the topic of reproductive health equity for women in recovery. Justice in this context refers to achieving the fair distribution of reproductive health-related benefits. Services should be provided on the basis of need and the burdens an costs should be on those who endanger the public health (Longest, 2016).
Women in recovery have well documented needs and desires for quality reproductive healthcare (Black & Day, 2016). Currently, many barriers exist for this population to access care to which they are entitled. Integration of reproductive healthcare into programs that directly serve this population can reduce these barriers and more fairly distribute reproductive healthcare (Black & Day, 2016).
It would follow ethical principles to require “those who endanger the public health” to assume some of the burden of funding new integrated programs. Allocating portions of settlement funds from major companies found to have profited from and contributed to the opioid crises is a partial remedy to consider. Purdue Pharma, Johnson & Johnson, Endo International, and Allergan are all healthcare giants that are currently considering large financial settlements to resolve opioid suits (Mann, Dwyer, & Castele, 2019)
Nonmaleficence is the ethical concept that our efforts must seek to do no harm (Longest, 2016). To avoid harm in family planning we must be cautious to avoid coercion and intentional in how we measure our “success” to ensure our measurements reflect our values (Dehlendorf, Bellanca, & Policar, 2015). Currently the Office of Population Affairs (OPA) collects data on two outcome measurements related to contraceptive care: “most & moderately effective method” use and “access to long acting reversible contraception (LARC).” It is important for programs and providers to understand that the OPA intentionally does not set benchmarks for these measures and does not expect the former to reach 100% nor the latter to be used to promote LARCs above all other options. It is inappropriate and unethical to use these outcomes in a pay-for-performance context as this could lead to coericion (USDHHS & OPA, 2020).
Beneficence is the ethical principle that actions are taken on the basis of seeking to do good with kindness and charity to maximize the benefits to society as a whole and balance the benefits and burdens (Longest, 2016). The OPA recognizes that a complimentary measurement is needed to monitor program “successes” based on the patient-reported, client experience of care with contraceptive services. Efforts have been made to develop validated scales to measure this (Dehlendorf, Henderson, Vittinghoff, Steinauer, Hessler, 2018). Consideration could be given to tying this type of measurement to pay-for-performance measures at it would reinforce the person-centered, ethical principles of care. In this way, quality family planning does good by empowering women to have the information and support they need to make decisions for themselves and enable them to received care they desire. This type of support has been described in the literature as “joint decision making” and more recently as “shared decision making” (Dehlendorf, Grumbach, Schmittdiel, & Steinauer, 2017).
References
Dehlendorf, C., Bellanca, H., & Policar, M. (2015). Performance measures for contraceptive care: What are we actually trying to measure? Contraception; 91(6):433-437.
Dehlendorf C., Grumbach, K., Schmittdiel, J.A., & Steinauer, J. (2017). Shared decision making in contraceptive counseling. Contraception. PMID: 28069491.
Dehlendorf, C., Henderson, J.T., Vittinghoff, E., Steinauer, J., & Hessler, D. (2018). Development of a patient-reported measure of the interpersonal quality of family planning care. Contraception; 97:34–40. PMID:28935217.
Mann, B., Dwyer, D., & Castele, N. (2019, Aug 28). Not just Purdue: Big drug companies considering settlements to resolve opioid suits. Retrieved from https://www.npr.org/2019/08/28/755007841/several-big-drug-companies-considering-massive-settlements-to-resolve-opioid-sui?t=1580131657883
Power to Decide. (2018, July). Access is power: Opioid use disorder and reproductive health. Retrieved from https://powertodecide.org/system/files/resources/primary-download/Opioid%20Use%20Disorder%20and %20Reproductive%20Health%20.pdf
U.S. Department of Health & Human Services, Office of Population Affairs. (2020). Performance measures. Retrieved from https://www.hhs.gov/opa/performance-measures/index.html









